These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9712059)

  • 41. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
    Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
    J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.
    Mackey MF; Gunn JR; Ting PP; Kikutani H; Dranoff G; Noelle RJ; Barth RJ
    Cancer Res; 1997 Jul; 57(13):2569-74. PubMed ID: 9205055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
    Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y
    J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the endogenous production of interleukin 12 in immunotherapy.
    Harada M; Tamada K; Abe K; Yasumoto K; Kimura G; Nomoto K
    Cancer Res; 1998 Jul; 58(14):3073-7. PubMed ID: 9679973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.
    Fioretti F; Fradelizi D; Stoppacciaro A; Ramponi S; Ruco L; Minty A; Sozzani S; Garlanda C; Vecchi A; Mantovani A
    J Immunol; 1998 Jul; 161(1):342-6. PubMed ID: 9647242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.
    Liu Y; Qureshi M; Xiang J
    Cancer Biother Radiopharm; 2002 Feb; 17(1):11-8. PubMed ID: 11915168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes.
    Yang G; Mizuno MT; Hellström KE; Chen L
    J Immunol; 1997 Jan; 158(2):851-8. PubMed ID: 8993003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity.
    Peng SL; McNiff JM; Madaio MP; Ma J; Owen MJ; Flavell RA; Hayday AC; Craft J
    J Immunol; 1997 Mar; 158(5):2464-70. PubMed ID: 9036998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT).
    Harada M; Matsunaga K; Oguchi Y; Iijima H; Ito O; Tamada K; Kimura G; Nomoto K
    Cancer Res; 1995 Dec; 55(24):6146-51. PubMed ID: 8521406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
    Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
    Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.
    Couderc B; Zitvogel L; Douin-Echinard V; Djennane L; Tahara H; Favre G; Lotze MT; Robbins PD
    Cancer Gene Ther; 1998; 5(3):163-75. PubMed ID: 9622100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis.
    Campos-Neto A; Ovendale P; Bement T; Koppi TA; Fanslow WC; Rossi MA; Alderson MR
    J Immunol; 1998 Mar; 160(5):2037-41. PubMed ID: 9498737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective antibodies in murine Lyme disease arise independently of CD40 ligand.
    Fikrig E; Barthold SW; Chen M; Grewal IS; Craft J; Flavell RA
    J Immunol; 1996 Jul; 157(1):1-3. PubMed ID: 8683101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.
    Lode HN; Xiang R; Pertl U; Förster E; Schoenberger SP; Gillies SD; Reisfeld RA
    J Clin Invest; 2000 Jun; 105(11):1623-30. PubMed ID: 10841521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exogenous CD40 ligand induces a pulmonary inflammation response.
    Wiley JA; Geha R; Harmsen AG
    J Immunol; 1997 Mar; 158(6):2932-8. PubMed ID: 9058832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.